These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 32782316)
41. A novel Nlrp3 knock-in mouse model with hyperactive inflammasome in development of lethal inflammation. Zhou Y; Yang X; Zhu L Clin Exp Immunol; 2024 Feb; 215(2):202-214. PubMed ID: 37594231 [TBL] [Abstract][Full Text] [Related]
42. Divergence of IL-1, IL-18, and cell death in NLRP3 inflammasomopathies. Brydges SD; Broderick L; McGeough MD; Pena CA; Mueller JL; Hoffman HM J Clin Invest; 2013 Nov; 123(11):4695-705. PubMed ID: 24084736 [TBL] [Abstract][Full Text] [Related]
43. Enhanced expression of NLRP3 inflammasome-related inflammation in peripheral blood mononuclear cells in Sjögren's syndrome. Kim SK; Choe JY; Lee GH Clin Chim Acta; 2017 Nov; 474():147-154. PubMed ID: 28965771 [TBL] [Abstract][Full Text] [Related]
44. Activation of the NLRP3 inflammasome in microglia: the role of ceramide. Scheiblich H; Schlütter A; Golenbock DT; Latz E; Martinez-Martinez P; Heneka MT J Neurochem; 2017 Dec; 143(5):534-550. PubMed ID: 28940479 [TBL] [Abstract][Full Text] [Related]
45. The mechanism of NLRP3 inflammasome initiation: Trimerization but not dimerization of the NLRP3 pyrin domain induces robust activation of IL-1β. Sušjan P; Roškar S; Hafner-Bratkovič I Biochem Biophys Res Commun; 2017 Feb; 483(2):823-828. PubMed ID: 28065854 [TBL] [Abstract][Full Text] [Related]
46. Vascular endothelial cells senescence is associated with NOD-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome activation via reactive oxygen species (ROS)/thioredoxin-interacting protein (TXNIP) pathway. Yin Y; Zhou Z; Liu W; Chang Q; Sun G; Dai Y Int J Biochem Cell Biol; 2017 Mar; 84():22-34. PubMed ID: 28064010 [TBL] [Abstract][Full Text] [Related]
47. NLRP3 inflammasome may regulate inflammatory response of human periodontal ligament fibroblasts in an apoptosis-associated speck-like protein containing a CARD (ASC)-dependent manner. Lu WL; Song DZ; Yue JL; Wang TT; Zhou XD; Zhang P; Zhang L; Huang DM Int Endod J; 2017 Oct; 50(10):967-975. PubMed ID: 27864974 [TBL] [Abstract][Full Text] [Related]
48. Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome. Shao A; Wu H; Hong Y; Tu S; Sun X; Wu Q; Zhao Q; Zhang J; Sheng J Mol Neurobiol; 2016 Jul; 53(5):3462-3476. PubMed ID: 26091790 [TBL] [Abstract][Full Text] [Related]
49. Early canakinumab therapy for the sensorineural deafness in a family with Muckle-Wells syndrome due to a novel mutation of NLRP3 gene. Iida Y; Wakiguchi H; Okazaki F; Nakamura T; Yasudo H; Kubo M; Sugahara K; Yamashita H; Suehiro Y; Okayama N; Hashimoto K; Iwamoto N; Kawakami A; Aoki Y; Takada H; Ohga S; Hasegawa S Clin Rheumatol; 2019 Mar; 38(3):943-948. PubMed ID: 30338413 [TBL] [Abstract][Full Text] [Related]
50. Methods to Activate the NLRP3 Inflammasome. Saller BS; Neuwirt E; Groß O Methods Mol Biol; 2023; 2696():169-197. PubMed ID: 37578723 [TBL] [Abstract][Full Text] [Related]
51. Confounding role of tumor necrosis factor in cryopyrin-associated periodic syndromes. Banoth B; Sutterwala FS J Clin Invest; 2017 Dec; 127(12):4235-4237. PubMed ID: 29130931 [TBL] [Abstract][Full Text] [Related]
52. Prostaglandin E2 Inhibits NLRP3 Inflammasome Activation through EP4 Receptor and Intracellular Cyclic AMP in Human Macrophages. Sokolowska M; Chen LY; Liu Y; Martinez-Anton A; Qi HY; Logun C; Alsaaty S; Park YH; Kastner DL; Chae JJ; Shelhamer JH J Immunol; 2015 Jun; 194(11):5472-5487. PubMed ID: 25917098 [TBL] [Abstract][Full Text] [Related]
53. Clinical and Molecular Phenotypes of Low-Penetrance Variants of NLRP3: Diagnostic and Therapeutic Challenges. Kuemmerle-Deschner JB; Verma D; Endres T; Broderick L; de Jesus AA; Hofer F; Blank N; Krause K; Rietschel C; Horneff G; Aksentijevich I; Lohse P; Goldbach-Mansky R; Hoffman HM; Benseler SM Arthritis Rheumatol; 2017 Nov; 69(11):2233-2240. PubMed ID: 28692792 [TBL] [Abstract][Full Text] [Related]
54. Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders. Jiang H; He H; Chen Y; Huang W; Cheng J; Ye J; Wang A; Tao J; Wang C; Liu Q; Jin T; Jiang W; Deng X; Zhou R J Exp Med; 2017 Nov; 214(11):3219-3238. PubMed ID: 29021150 [TBL] [Abstract][Full Text] [Related]
55. Increased expression of NLRP3 inflammasome components and interleukin-18 in patients with bullous pemphigoid. Fang H; Shao S; Cao T; Lei J; Dang E; Zhang J; Wang G J Dermatol Sci; 2016 Aug; 83(2):116-23. PubMed ID: 27174093 [TBL] [Abstract][Full Text] [Related]
56. Tetrachlorobenzoquinone Stimulates NLRP3 Inflammasome-Mediated Post-Translational Activation and Secretion of IL-1β in the HUVEC Endothelial Cell Line. Xia X; Shi Q; Song X; Fu J; Liu Z; Wang Y; Wang Y; Su C; Song E; Song Y Chem Res Toxicol; 2016 Mar; 29(3):421-9. PubMed ID: 26901245 [TBL] [Abstract][Full Text] [Related]
57. No NLRP3 inflammasome activity in kidney epithelial cells, not even when the NLRP3-A350V Muckle-Wells variant is expressed in podocytes of diabetic mice. Kunte SC; Marschner JA; Klaus M; Honda T; Li C; Motrapu M; Walz C; Angelotti ML; Antonelli G; Melica ME; De Chiara L; Semeraro R; Nelson PJ; Anders HJ Front Immunol; 2023; 14():1230050. PubMed ID: 37744356 [TBL] [Abstract][Full Text] [Related]
58. Simvastatin Suppresses Interleukin Iβ Release in Human Peripheral Blood Mononuclear Cells Stimulated With Cholesterol Crystals. Boland AJ; Gangadharan N; Kavanagh P; Hemeryck L; Kieran J; Barry M; Walsh PT; Lucitt M J Cardiovasc Pharmacol Ther; 2018 Nov; 23(6):509-517. PubMed ID: 29764192 [TBL] [Abstract][Full Text] [Related]
59. Dental Calculus Stimulates Interleukin-1β Secretion by Activating NLRP3 Inflammasome in Human and Mouse Phagocytes. Montenegro Raudales JL; Yoshimura A; Sm Z; Kaneko T; Ozaki Y; Ukai T; Miyazaki T; Latz E; Hara Y PLoS One; 2016; 11(9):e0162865. PubMed ID: 27632566 [TBL] [Abstract][Full Text] [Related]
60. A novel knock-in mouse model of cryopyrin-associated periodic syndromes with development of amyloidosis: Therapeutic efficacy of proton pump inhibitors. Bertoni A; Carta S; Baldovini C; Penco F; Balza E; Borghini S; Di Duca M; Ognio E; Signori A; Nozza P; Schena F; Castellani P; Pastorino C; Perrone C; Obici L; Martini A; Ceccherini I; Gattorno M; Rubartelli A; Chiesa S J Allergy Clin Immunol; 2020 Jan; 145(1):368-378.e13. PubMed ID: 31194989 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]